NeuroSense Therapeutics Ltd. Warrant (NRSNW) Stock Analysis

NeuroSense Therapeutics Ltd. Warrant (NRSNW) is a publicly traded company in the HEALTHCARE sector. It trades at $0.13. This page summarizes the public market data, fundamentals, and frequently asked questions for NRSNW, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.13
• EPS: $-0.94
• 52-Week High: $1.00
• 52-Week Low: $0.13

About NeuroSense Therapeutics Ltd. Warrant

None

GNG Research Analysis

GNG Research scores NeuroSense Therapeutics Ltd. Warrant (NRSNW) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NRSNW.

Frequently Asked Questions

Does NRSNW pay dividends?

NeuroSense Therapeutics Ltd. Warrant (NRSNW) does not currently pay a regular dividend.